Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten public offering of 8M shares at $4. The company intends to use the net proceeds from the offering to fund its clinical trial and manufacturing program.
Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten...
From other sites
at CNBC.com (Sep 12, 2012)
at CNBC.com (Apr 7, 2011)
at CNBC.com (Apr 4, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs